surmount-1 tirzepatide 15 mg weight loss percent Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Hasanuzzaman, M., Nahar, K., Anee, T

It is designed to be mixed with water or beverages as part of a daily routine

The most common side effects of GLP-1 drugs are gastrointestinal, such as nausea, vomiting, and diarrhea

Tirzepatide left at room temperature for more than 2 hours loses potency and should be discarded

It specializes in sterile and non-sterile compounded medications using robotic isolator systems for injectable production

This dual effect makes it a promising candidate for muscle growth and metabolic improvement, especially in populations with lipodystrophy (a group of disorders that affect how the body stores fat) or sarcopenia (age-related muscle loss) (15)